Tag: Therapeutic Goods Administration
VVMF receives TGA manufacturing licence for Sydney viral vector facility
Viral Vector Manufacturing Facility Pty Ltd (VVMF) has received a Therapeutic Goods Administration (TGA) manufacturing licence for its Sydney facility, allowing the company to manufacture viral vectors under Good Manufacturing Practice (GMP) conditions.
WA hospital begins manufacturing breakthrough cancer therapies
Western Australia has taken a step towards locally manufacturing advanced cancer therapies, with Royal Perth Hospital licensed to manufacture CAR T-cells and becoming the first hospital in Australia authorised to manufacture tumour-infiltrating lymphocytes (TILs) for clinical trials.
TGA issues latest manufacturing licensing decisions for Australian therapeutic goods sector
The Therapeutic Goods Administration (TGA) has released its latest update on regulatory decisions affecting Australian therapeutic goods manufacturing, announcing changes to manufacturing licences held by manufacturers across the country.
Raising the standard: Why Australia’s next manufacturing advantage will be built on quality
Australia's manufacturing sector is entering a new phase.
TGA updates Australian manufacturing licences with new approvals and regulatory actions
The Therapeutic Goods Administration (TGA) has released its latest list of decisions relating to Australian manufacturers licensed to produce therapeutic goods, outlining new manufacturing approvals alongside changes to existing licences as part of its ongoing regulatory oversight.
TGA urges manufacturers to provide feedback on updated GMP guidelines
The Therapeutic Goods Administration (TGA) is encouraging Australian manufacturers to take part in an international consultation on proposed updates to Good Manufacturing Practice (GMP) guidelines, as the standards move to reflect advances in digital technology and artificial intelligence.
Bioxyne granted Australia’s first GMP licence for Psilocybin and MDMA manufacturing
Bioxyne Limited's subsidiary, Breathe Life Sciences (BLS), has secured the Good Manufacturing Practice (GMP) licence for the production of medical cannabis.
Patient-ready MDMA lands in Australia for GMP standard manufacturing
Australian medicinal cannabis company Vitura Health Limited has released an update on its Cortexa Joint Venture with PharmAla Biotech after landing bulk GMP Active Pharmaceutical Ingredient (API) for MDMA (3,4-Methylenedioxy-methamphetamine) in Australia.
Cann granted GMP manufacturing licence for Mildura facility
The Therapeutic Goods Administration (TGA) has granted Cann Group Limited a GMP licence to manufacture therapeutic goods, which includes GMP testing at its Mildura facility.
Cann...
Securing Rapid Tests And Making Them In Victoria
Media Release by the Premier of Victoria
The Victorian Government is supporting local manufacturing of Rapid Antigen Tests (RATs) to help secure critical supplies for...
Featured Article
Xometry CEO Sanjeev Singh Sahni on how AI and digital networks are reshaping manufacturing supply chains
Australian manufacturers have long competed against distance. In an exclusive interview with Australian Manufacturing, Xometry CEO Sanjeev Singh Sahni discusses how AI can help manufacturers access more production capacity and simplify traditionally email-driven supply chains.
